I am a radiation oncologist specializing in the use of image-guided radiotherapy for the treatment of spine tumors. This treatment utilizes intensity-modulated radiotherapy and stereotactic radiosurgery techniques to deliver safe and effective radiation to tumors of the spine. I work closely with an interdisciplinary team of surgeons, medical physicists, radiologists, and nurses to provide high-quality, personalized treatment for each patient.
I am also the principal investigator of a laboratory that aims to understand the role of noncoding elements of the genome in cancer. We are just beginning to appreciate how these components of the genome are frequently mutated in cancer in ways that can significantly impact cellular physiology. We believe that characterizing the function of these elements will provide important insights into cancer development and behavior that may ultimately lead to improved cancer therapy.
- Clinical Expertise: Spine Tumors; Stereotactic Body Radiotherapy; Image Guided Radiotherapy
- Languages Spoken: English
- Education: MD, University of Chicago
- Residencies: Radiation Oncology - Stanford Cancer Institute
- Fellowships: Radiation Oncology - Stanford Cancer Institute
- Board Certifications: Radiation Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more